Zoetis (ZTS) shares hit a new 52-week low on September 21, 2026. The stock traded as low as $70.54. The decline follows cautious analyst updates amid a challenging animal health market. The consensus rating for the stock is a "Hold."
TD Cowen lowered its price target on Zoetis to $94 from $104. The firm maintained a "Buy" rating. TD Cowen cited declining veterinary clinic visits, increased competition, and pricing pressure for the adjustment. Stifel and William Blair have also recently adjusted their outlooks or ratings on Zoetis.